Study design of heart failure events reduction with remote monitoring and eHealth support (HERMeS)
Author
Yun, Sergi
Enjuanes-Grau, Cristina
Calero, Esther
Hidalgo, Encarnación
Cobo, Marta
Llàcer, Pau
García Pinilla, José Manuel
González Franco, Álvaro
Núñez, Julio
Morales Rull, José Luis
Beltrán, Paola
Delso, Cristina
Freixa Pamias, Román
Moliner, Pedro
Corbella Virós, Xavier
Comin-Colet, Josep
HERMeS trial investigators group
Publication date
2020ISSN
2055-5822
Abstract
Aims: The role of non‐invasive telemedicine (TM) combining telemonitoring and teleintervention by videoconference (VC) in patients recently admitted due to heart failure (HF) (‘vulnerable phase’ HF patients) is not well established. The aim of the Heart failure Events reduction with Remote Monitoring and eHealth Support (HERMeS) trial is to assess the impact on clinical outcomes of implementing a TM service based on mobile health (mHealth), which includes remote daily monitoring of biometric data and symptom reporting (telemonitoring) combined with VC structured, nurse‐based follow‐up (teleintervention). The results will be compared with those of the comprehensive HF usual care (UC) strategy based on face‐to‐face on‐site visits at the vulnerable post‐discharge phase. Methods and results: We designed a 24 week nationwide, multicentre, randomized, controlled, open‐label, blinded endpoint adjudication trial to assess the effect on cardiovascular (CV) mortality and non‐fatal HF events of a TM‐based comprehensive management programme, based on mHealth, for patients with chronic HF. Approximately 508 patients with a recent hospital admission due to HF decompensation will be randomized (1:1) to either structured follow‐up based on face‐to‐face appointments (UC group) or the delivery of health care using TM. The primary outcome will be a composite of death from CV causes or non‐fatal HF events (first and recurrent) at the end of a 6 month follow‐up period. Key secondary endpoints will include components of the primary event analysis, recurrent event analysis, and patient‐reported outcomes. Conclusions: The HERMeS trial will assess the efficacy of a TM‐based follow‐up strategy for real‐world ‘vulnerable phase’ HF patients combining telemonitoring and teleintervention.
Document Type
Article
Document version
Published version
Language
English
Subject (CDU)
61 - Medical sciences
616.1 - Pathology of the circulatory system, blood vessels. Cardiovascular complaints
Keywords
Insuficiència cardíaca
Telemedicina
Videoconferències
Hospitals -- Pacients
Símptomes
Assistència sanitària
Insuficiencia cardíaca
Telemedicina
Videoconferencia
Hospitalizados
Sintomatología
Asistencia sanitaria
Heart failure
Telemedicine
Video conferencing
Hospitals -- Patients
Symptoms
Health care
Pages
10
Publisher
John Wiley & Sons
Is part of
ESC Heart Failure
Citation
Yun, Sergi; Enjuanes, Cristina; Calero, Esther [et al.]. Study design of heart failure events reduction with remote monitoring and eHealth support (HERMeS). ESC Heart Failure, 2020, p. 1-10. Disponible en: <https://onlinelibrary.wiley.com/doi/10.1002/ehf2.12962>. Fecha de acceso: 3 nov. 2020. DOI: 10.1002/ehf2.12962
This item appears in the following Collection(s)
- Ciències de la Salut [740]
Rights
© 2020 The Authors. ESC Heart Failure published by John Wiley & Sons Ltd on behalf of European Society of Cardiology. This is an open access article under the terms of the Creative Commons Attribution‐NonCommercial‐NoDerivs License, which permits use and distribution in any medium, provided the original work is properly cited, the use is non‐commercial and no modifications or adaptations are made.
Except where otherwise noted, this item's license is described as https://creativecommons.org/licenses/by-nc-nd/4.0/